Clinical Study and Gene Mutation Analysis of Adrenoleukodystrophy in Taiwanese Children

The recruitment status of this study is unknown because the information has not been verified recently.

Verified January 2006 by Far Eastern Memorial Hospital.
Recruitment status was Recruiting

Sponsor:

Collaborators:

National Taiwan University Hospital

Fu Jen Catholic University

Information provided by:

Far Eastern Memorial Hospital

ClinicalTrials.gov Identifier:

NCT00278044

First received: January 16, 2006

Last updated: February 6, 2009

Last verified: January 2006

History of Changes

Purpose

Study the clinical manifestations and gene mutation of Taiwanese ALD patients

Condition	Intervention
Adrenoleukodystrophy	Procedure: blood sampling and medical records


Study Type:	Interventional
Study Design:	Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic
Official Title:	Clinical Study and Gene Mutation Analysis of Adrenoleukodystrophy in Taiwanese Children

Resource links provided by NLM:

Genetics Home Reference related topics: CASK-related intellectual disability D-bifunctional protein deficiency MECP2 duplication syndrome PPM-X syndrome Renpenning syndrome SYNGAP1-related intellectual disability X-linked adrenoleukodystrophy alpha-methylacyl-CoA racemase deficiency familial glucocorticoid deficiency leukoencephalopathy with vanishing white matter megalencephalic leukoencephalopathy with subcortical cysts peroxisomal acyl-CoA oxidase deficiency succinic semialdehyde dehydrogenase deficiency

MedlinePlus related topics: Genes and Gene Therapy

Genetic and Rare Diseases Information Center resources: X-linked Adrenoleukodystrophy Adrenomyeloneuropathy Peroxisomal Biogenesis Disorders Hypoadrenalism

U.S. FDA Resources

Further study details as provided by Far Eastern Memorial Hospital:


Estimated Enrollment:	20
Study Start Date:	January 2006
Estimated Study Completion Date:	July 2007

Eligibility


Ages Eligible for Study:	Child, Adult, Senior
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

X-ALD patients and family

Exclusion Criteria:

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00278044

Contacts


Contact: jao shwann liang, MD	02-89667000 ext 4448	j580414@yahoo.com.tw

Locations


Taiwan
Far Eastern Memorial Hospital	Recruiting
Taipei, Taiwan, 220
Contact: Jao Shwann Liang, MD 02-8966-7000 ext 4448 j580414@yahoo.com.tw

Sponsors and Collaborators

Far Eastern Memorial Hospital

National Taiwan University Hospital

Fu Jen Catholic University

Investigators


Principal Investigator:	Jao Shwann Liang, MD	Far Eastern Memorial Hospital

More Information


ClinicalTrials.gov Identifier:	NCT00278044 History of Changes
Other Study ID Numbers:	94028
Study First Received:	January 16, 2006
Last Updated:	February 6, 2009
Health Authority:	Taiwan: Department of Health

Keywords provided by Far Eastern Memorial Hospital:


Search as text words in Annotation & Scope Note

Additional relevant MeSH terms:


Adrenoleukodystrophy Brain Diseases, Metabolic, Inborn Brain Diseases, Metabolic Brain Diseases Central Nervous System Diseases Nervous System Diseases Hereditary Central Nervous System Demyelinating Diseases Leukoencephalopathies Demyelinating Diseases Mental Retardation, X-Linked Intellectual Disability	Neurobehavioral Manifestations Neurologic Manifestations Genetic Diseases, X-Linked Genetic Diseases, Inborn Heredodegenerative Disorders, Nervous System Metabolism, Inborn Errors Peroxisomal Disorders Metabolic Diseases Adrenal Insufficiency Adrenal Gland Diseases Endocrine System Diseases

ClinicalTrials.gov processed this record on September 27, 2016

To Top